Harwood Advisory »

Enlivex Therapeutics shares owned by Harwood Advisory

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Harwood Advisory from 13F filings

Historical chart of Harwood Advisory investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Harwood Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Harwood Advisory

Quarter filed Position value Share count Share price at filing
2026-06-30 $82 150 0.55

More positions owned by Harwood Advisory

Select Sector Spdr Tr St Str Techn Etf (XLK)
Vaneck Etf Trust Clo Etf (CLOI)
Ishares Tr Msci Eafe Etf (EFA)
Horizon Fds Anfield Universl (AFIF)
Vanguard World Mega Grwth Ind (MGK)
Ishares Msci Emrg Chn (EMXC)
First Tr Exchng Traded Fd Vi Smit Unco Bd Etf (UCON)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Mbs Etf (MBB)
Pimco Etf Tr Active Bd Etf (BOND)
New York Life Invts Active E Mackay Mun Inter (MMIT)
Lam Research Corp Com New (LRCX)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr St Str Svc Etf (XLC)

View all positions for Harwood Advisory

Top funds holding Enlivex Therapeutics

ARK Investment Management
Springbok Capital Management
Bank of America Corporation
Two Sigma Investments
Susquehanna International
Persistent Asset Partners
Renaissance Technologies
Geode Capital Management
Jpmorgan Chase & Co
Simplex Trading
Winton Capital
Goldman Sachs Group
Citadel Advisors
UBS Group
Hrt Financial

View all funds holding Enlivex Therapeutics